ArticleJournal of experimental & clinical cancer research : CR2026

GFAT2-mediated HSPD1 O-GlcNAcylation drives chemotherapy resistance in non-small cell lung cancer.

Man Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.